(Q30308666)

English

Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Inhibition by R(+) or S(-) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH-SY5Y neuroblastoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nicole A Abramova

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

David S Cassarino

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Shaharyar M Khan

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Terry W Painter

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

James P Bennett

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

67

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

494-500

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Neuroprotective effects of pramipexole in young and aged MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Energetics in the pathogenesis of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effects of MPP+

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

MPP+ induced SH-SY5Y apoptosis is potentiated by cyclosporin A and inhibited by aristolochic acid

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Characterization and time course of MPP+ -induced apoptosis in human SH-SY5Y neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Activation of caspase-3 in beta-amyloid-induced apoptosis of cultured rat cortical neurons

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Release and aggregation of cytochrome c and alpha-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Origin and functional consequences of the complex I defect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Cybrids in Alzheimer's disease: a cellular model of the disease?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Mitochondria in sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Maternal inheritance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.10127

21 January 2018

Identifiers

10.1002/JNR.10127

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30308666&oldid=1719152667"